Clinical Report: Reduced-Dose Radiation Shows Durable Control

Overview

A cohort study found that a deintensified 60-Gy radiotherapy regimen resulted in low long-term locoregional recurrence rates among selected patients with HPV-associated oropharyngeal carcinoma. The study demonstrated a 5-year locoregional recurrence rate of 3.4% and overall survival of 92.4%.

Background

The management of HPV-associated oropharyngeal carcinoma (OPC) is evolving, with ongoing discussions about the potential for deintensified treatment regimens. Standard treatment typically involves higher doses of radiotherapy, which can lead to significant side effects. Understanding the efficacy and safety of reduced-dose regimens is crucial for optimizing patient outcomes and minimizing treatment-related morbidity.

Data Highlights

Key Findings

• 5-year locoregional recurrence rate was 3.4% among patients treated with 60 Gy.
• Overall survival at 5 years was 92.4%, indicating favorable long-term outcomes.
• Progression-free survival was 86.5%, with nodal stage being the only independent factor associated with progression-free survival events.
• 46.2% of recurrences occurred more than 2 years after treatment, suggesting the need for prolonged surveillance.
• Among lower-risk patients treated with radiotherapy alone, the 5-year progression-free survival was 93.8% with no locoregional recurrences.

Clinical Implications

The findings support the consideration of reduced-dose radiotherapy in carefully selected patients with HPV-associated OPC, particularly those with lower-risk disease. Clinicians should engage in informed discussions with patients about the potential benefits and risks of deintensified treatment approaches.

Conclusion

This study provides evidence that a modest dose deintensification of radiotherapy can achieve durable locoregional control in HPV-associated OPC, although it does not alter the current standard of care.

Related Resources & Content

1. Ryan T. Morse, MD, et al., JAMA Otolaryngology–Head & Neck Surgery, 2023 -- Reduced-Dose Radiation Shows Durable Control
2. roswell park comprehensive cancer center — Single Dose of Radiation as Effective as 5-Week Course for Lung Cancer: Roswell Park Shares Results at ASTRO
3. fox chase cancer center — Newer Radiation Technique Reduces Side Effects While Maintaining Effectiveness
4. the asco post — Intermediate-Risk Prostate Cancer: Shorter Radiation Improves Patient Experience, But Not Disease Control
5. the asco post — Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma
6. Single Dose of Radiation as Effective as 5-Week Course for Lung Cancer: Roswell Park Shares Results at ASTRO
7. Newer Radiation Technique Reduces Side Effects While Maintaining Effectiveness
8. Intermediate-Risk Prostate Cancer: Shorter Radiation Improves Patient Experience, But Not Disease Control
9. HPV-positive OPSCC Guideline - American Society for Radiation Oncology (ASTRO)
10. Reduced-Dose Radiation Therapy for HPV-Associated... : Journal of Clinical Oncology
11. FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial - PubMed